Asgarlou Zoleykha, Mohammadian Elham Dehghanpour, Houshmandi Sousan, Mohseni Mohammad, Sheyklo Sepideh Gareh, Moosavi Ahmad, Ahmadi Shiler
Department of Reproductive Health and Midwifery, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Department of Midwifery, Faculty of Nursing and Midwifery, Islamic Azad University, Zanjan Branch, Zanjan, Iran.
Int J Prev Med. 2023 Sep 28;14:116. doi: 10.4103/ijpvm.ijpvm_250_22. eCollection 2023.
Antiemetic medications have been associated with the prevention of nausea and vomiting in cesarean section, although less is known about the comparative efficacy of different medication classes.
We conducted a systematic review with network meta-analyses to compare and rank antiemetic medication classes (5-HT3 receptor antagonists, dopamine receptor antagonists, corticosteroids, antihistamines, anticholinergic agents, sedatives, and opioid antagonists or partial agonists) in terms of preventing intra- and postoperative nausea and vomiting among patients undergoing cesarean section. We included all randomized controlled trials (RCTs) that evaluated any antiemetic medication classes' treatment for target outcomes. Network meta-analysis was conducted with a frequentist approach using the R package. A total of 58 trials were included (6,665 women undergoing cesarean section; mean age, 28.1 years). Results: Compared with placebo, all interventions reduced the odds of intraoperative nausea (except antihistamines), intraoperative vomiting (except antihistamines), postoperative nausea (except anticholinergic agents and opioid antagonists), and postoperative vomiting (except opioid antagonists). In terms of intraoperative nausea and both intra- and postoperative vomiting, sedatives ranked first among other medication classes.
The relative effect sizes for various classes of antiemetic medication in preventing nausea and vomiting in the cesarean section were modeled using the principles of network meta-analysis which may facilitate informed clinical decision-making.
尽管对于不同类别药物的比较疗效了解较少,但止吐药物已被证实与剖宫产术中恶心和呕吐的预防相关。
我们进行了一项系统评价及网状Meta分析,以比较并排序各类止吐药物(5-羟色胺3受体拮抗剂、多巴胺受体拮抗剂、皮质类固醇、抗组胺药、抗胆碱能药物、镇静剂以及阿片类拮抗剂或部分激动剂)在预防剖宫产患者术中及术后恶心和呕吐方面的效果。我们纳入了所有评估任何止吐药物类别对目标结局治疗效果的随机对照试验(RCT)。使用R软件包,采用频率学派方法进行网状Meta分析。共纳入58项试验(6665例接受剖宫产的女性;平均年龄28.1岁)。结果:与安慰剂相比,所有干预措施均降低了术中恶心(抗组胺药除外)、术中呕吐(抗组胺药除外)、术后恶心(抗胆碱能药物和阿片类拮抗剂除外)以及术后呕吐(阿片类拮抗剂除外)的发生几率。在术中恶心以及术中与术后呕吐方面,镇静剂在其他药物类别中排名第一。
运用网状Meta分析的原理对各类止吐药物在预防剖宫产术中恶心和呕吐方面的相对效应量进行了建模,这可能有助于做出明智的临床决策。